Acutus Medical, Inc. AFIB

Company Overview

Acutus Medical, Inc. is a U.S.-based medical technology company focused on the diagnosis and treatment of complex cardiac arrhythmias, particularly atrial fibrillation (AF) and ventricular arrhythmias. The company operates within the cardiac electrophysiology segment of the broader medical devices industry, developing technologies intended to improve the precision and efficiency of arrhythmia mapping and ablation procedures. Its core value proposition centers on enabling electrophysiologists to visualize and treat arrhythmias with greater accuracy compared to conventional mapping approaches.

The company’s primary revenue drivers have historically included advanced cardiac mapping systems, diagnostic catheters, and related accessories used in hospital electrophysiology labs. Acutus differentiates itself through high-resolution, noncontact mapping technology designed to rapidly map complex arrhythmias. Acutus Medical was founded in 2011 by Randall Wolf, a cardiothoracic surgeon and electrophysiologist, and went public in 2020. Since its IPO, the company has undergone multiple strategic and financial restructurings as it sought to scale adoption of its technology amid competitive and reimbursement pressures in the electrophysiology market.